IXICO plc (GB:IXI) has released an update.
IXICO plc, a leading analytics company in medical imaging, expects to surpass market expectations in FY24, thanks to new contracts amounting to £5.8 million since March. Anticipated revenues between £5.5 million and £5.9 million represent a significant second-half growth over H1, with a forecasted increase in year-end order books. These developments suggest an improved cash and EBITDA performance, propelling the company towards robust financial health.
For further insights into GB:IXI stock, check out TipRanks’ Stock Analysis page.
